eli lilly semaglutide Tirzepatide Tops for Weight Loss in Head-to-Head Trial, Says Eli Lilly loses weight loss

The problem many patients face is confusing tolerance with efficacy

Tirzepatide is different

While no head-to-head trials have compared GLP-1 drugs specifically for migraine outcomes, we can draw some inferences from their pharmacological profiles and side effect data

Titrating up too fast is the most common reason women drop out of protocols not because the peptide failed, but because the dose curve was wrong for their physiology

1 Finally, any program involving GLP-1s for weight loss should consider heart health

We ask first about her BMI, her cardiometabolic risk, her current screening schedule, and what her primary care or gynecology clinician has recommended